Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 8 opinions in the last 12 months.
Medtronic Inc (MDT) has been experiencing a resurgence following years of struggles, reflected in recent successful product launches that have rejuvenated its market presence. Experts acknowledge that while the stock has reached a 10-year low, it now appears attractively priced with a forward P/E ratio of approximately 15.9. The medical device sector's advantages, particularly in aging demographics and a shift towards more innovative medical solutions, present potential for growth. Although some experts express caution, indicating that the company must address several internal issues first, others highlight the recent solid earnings and 5.3% organic growth as indicators of its recovery and resilience. The incorporation of AI in their devices further underscores MDT's commitment to innovation in medical technology.
MDT is a mature MedTech company that is now trading at a 15.9x Forward P/E. Over the last few years, MDT’s valuation has ranged from 13.4x to 22.8x Forward P/E, we think the current valuation is fairly attractive. MDT’s share price has performed well recently due to a combination of 1) investors moving to defensive sectors with stable cash flows 2) MDT reported very solid earnings with a 5.3% organic growth rate.
Unlock Premium - Try 5i Free
MDT is a mature MedTech company that is now trading at a 15.9x Forward P/E. Over the last few years, MDT’s valuation has ranged from 13.4x to 22.8x Forward P/E, we think the current valuation is fairly attractive. MDT’s share price has performed well recently due to a combination of 1) investors moving to defensive sectors with stable cash flows 2) MDT reported very solid earnings with a 5.3% organic growth rate.
Unlock Premium - Try 5i Free
Ugly chart. Street opinion is a blend of Buy and Hold at these levels. She waits to see a trend reversal before getting in. Fundamentally, 9/10. Diverse portfolio, likes the positioning. Healthcare is great before a recession, but better names out there. Ride it out until you can break even.
(Analysts’ price target is $94.00)Medtronic Inc is a American stock, trading under the symbol MDT-N on the New York Stock Exchange (MDT). It is usually referred to as NYSE:MDT or MDT-N
In the last year, 18 stock analysts published opinions about MDT-N. 6 analysts recommended to BUY the stock. 6 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Medtronic Inc.
Medtronic Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Medtronic Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
18 stock analysts on Stockchase covered Medtronic Inc In the last year. It is a trending stock that is worth watching.
On 2025-04-25, Medtronic Inc (MDT-N) stock closed at a price of $84.16.
It's been lost in the wilderness for years, but has had a bunch of successful product launches and the stock is now cheap.